AINewsnow

VIDRAFT's PharmaOS Closes the Loop: AI Drug Discovery Gets Cell-Level Experimental Validation

This story is from 2026-09-12. It is preserved in the archive; the latest stories are on the live feed.

VIDRAFT's PharmaOS Closes the Loop: AI Drug Discovery Gets Cell-Level Experimental Validation TL;DR: VIDRAFT has partnered with Pyo Biotech to connect its AI-driven drug candidate discovery platform, PharmaOS, to real wet-lab cell experiments — bridging the gap between in silico prediction and in v…

Read the full story at DEV Community — Machine Learning ↗

Timeline · 1 report

  1. 2026-09-12 23:01 · DEV Community — Machine Learning
    VIDRAFT's PharmaOS Closes the Loop: AI Drug Discovery Gets Cell-Level Experimental Validation

More stories

  1. Trump announces a new 'AI Force,' but says he will not 'stifle' AI — Business Insider AI
  2. Anthropic, OpenAI, SpaceXAI, Google sued over call to ‘pace’ AI development — Politico Technology
  3. Introducing Kimi K3 on Amazon Bedrock — AWS Machine Learning Blog
  4. Introducing Amazon SageMaker HyperPod Inference Gateway — AWS Machine Learning Blog
  5. Google's Gemini AI hacks three other companies during security test — Sky News Technology
  6. Gemini Hacked Three Companies in First Known Breakout by Google’s AI — Wall Street Journal Technology
  7. OpenAI reveals cases of ‘concerning’ AI behaviour as it announces new disclosure system — The Guardian AI
  8. AI's role in building AI surging? Anthropic says Claude now leads 26% of its R&D — Mint AI

Get the daily brief of stories like this at 6:30 every morning →